Nexobrid Market Report 2026
Nexobrid Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Nexobrid Market Report 2026

Global Outlook – By Formulation (Topical Gel, Spray, Ointment), By Clinical Indication (Burn Care, Chronic Wound Care, Trauma Care), By Distribution Channel (Hospitals, Ambulatory Surgical Centers (ASCs), Retail Pharmacies, Online Pharmacies), By End-User (Adult, Pediatric, Geriatric) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Nexobrid Market Overview

• The Nexobrid market growth in the historic period has been driven by increasing incidence of severe burn injuries, limitations of surgical debridement methods

• Market expansion is supported by increasing demand for minimally invasive wound management, expansion of trauma care infrastructure

• Growth Driver: Rising Prevalence Of Burn Injuries To Drive The Market Growth

• Market Trend: Enhancing Emergency Preparedness With Advanced Burn Care Treatments

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nexobrid Market?

Nexobrid is a topical enzymatic debridement agent designed to treat severe burns. It selectively removes eschar while preserving healthy tissue, accelerating wound healing, and minimizing the need for surgical procedures. This advanced formulation enhances recovery outcomes and offers a non-invasive solution for burn care.

The main types of nexobrid formulations are topical gel, spray, and ointment. A topical gel formulation is designed for direct skin application, promoting healing by delivering active ingredients efficiently to the affected area. It is applicable in several clinical indications, such as burn care, chronic wound care, and trauma care, and is distributed through various distribution channels, including hospitals, ambulatory surgical centers (ASCs), retail pharmacies, and online pharmacies, and is used by several end users, such as adults, pediatrics, and geriatrics.

Nexobrid Market Global Report 2026 Market Report bar graph

What Is The Nexobrid Market Size and Share 2026?

The growth in the historic period can be attributed to increasing incidence of severe burn injuries, limitations of surgical debridement methods, expansion of specialized burn care units, rising awareness of advanced wound care therapies, improved access to topical enzymatic treatments.

What Is The Nexobrid Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for minimally invasive wound management, expansion of trauma care infrastructure, growing adoption of advanced enzymatic formulations, rising focus on patient recovery outcomes, increasing investments in next-generation burn care technologies. Major trends in the forecast period include increasing adoption of enzymatic burn debridement solutions, rising demand for non-surgical burn care treatments, growing focus on accelerated wound healing, expansion of advanced trauma and burn centers, enhanced emphasis on tissue preservation.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Nexobrid Market Segmentation

1) By Formulation: Topical Gel, Spray, Ointment

2) By Clinical Indication: Burn Care, Chronic Wound Care, Trauma Care

3) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Retail Pharmacies, Online Pharmacies

4) By End-User: Adult, Pediatric, Geriatric

What Is The Driver Of The Nexobrid Market?

The increasing prevalence of burn injuries is expected to fuel the growth of the nexobrid market going forward. Burn injuries refer to physical damage to the skin or other tissues leading to tissue destruction, pain, and impaired function. Occupational hazards in industries such as construction, manufacturing, and healthcare increase burn injury risks due to exposure to open flames, hot surfaces, and hazardous chemicals. Nexobrid aids in burn recovery by efficiently removing eschar from burn wounds, accelerating healing, and minimizing the need for surgery, ultimately enhancing patient outcomes. For instance, in October 2023, according to a report published by the World Health Organization, a Switzerland-based intergovernmental organization, approximately 180,000 deaths occur annually due to burns, with the majority happening in low- and middle-income countries. Therefore, the increasing prevalence of burn injuries will drive the nexobrid industry growth.

Key Players In The Global Nexobrid Market

Major companies operating in the nexobrid market are MediWound Ltd.

Global Nexobrid Market Trends and Insights

Major companies operating in the NexoBrid market are focusing on developing innovative solutions, such as eschar removal drugs, to meet the rising demand for effective, non-invasive burn care solutions. These drugs break down dead tissue (eschar) while preserving healthy tissue, providing a non-surgical alternative to traditional debridement. For instance, in August 2024, MediWound Ltd., an Israel-based biopharmaceutical company, announced that the U.S. FDA had approved NexoBrid (anacaulase-bcdb) for pediatric patients with deep partial-thickness or full-thickness thermal burns. The product features a proteolytic enzyme formulation that removes burn eschar within four hours, supports tissue regeneration, and reduces the need for surgical intervention. NexoBrid is approved in over 43 countries and is supported by BARDA.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Nexobrid Market?

In November 2024, MediWound Ltd., an Israel-based provider of enzymatic debridement products and advanced wound care therapies, partnered with PolyMedics Innovations to enhance wound care solutions. With this partnership, MediWound aims to expand the commercial reach of its NexoBrid product across key European markets, strengthen adoption in burn care centers, and complement PMI’s existing wound-healing product portfolio. PolyMedics Innovations GmbH is a Germany-based provider of advanced wound care and skin substitute solutions, including products such as SUPRATHEL and NovoSorb BTM.

Regional Insights

North America was the largest region in the nexobrid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Nexobrid Market?

The nexobrid market consists of sales of cream, liquid solution, and powder. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nexobrid Market Report 2026?

The nexobrid market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nexobrid industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Nexobrid Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Formulation, Clinical Indication, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled MediWound Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Nexobrid Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Nexobrid Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Nexobrid Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Nexobrid Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Industry 4.0 And Intelligent Manufacturing

4.1.3 Sustainability, Climate Tech And Circular Economy

4.1.4 Digitalization, Cloud, Big Data And Cybersecurity

4.1.5 Artificial Intelligence And Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Adoption Of Enzymatic Burn Debridement Solutions

4.2.2 Rising Demand For Non-Surgical Burn Care Treatments

4.2.3 Growing Focus On Accelerated Wound Healing

4.2.4 Expansion Of Advanced Trauma And Burn Centers

4.2.5 Enhanced Emphasis On Tissue Preservation

5. Nexobrid Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Burn Care Centers

5.3 Ambulatory Surgical Centers

5.4 Emergency Care Units

5.5 Specialty Wound Care Clinics

6. Nexobrid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nexobrid Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nexobrid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Nexobrid Market Size, Comparisons And Growth Rate Analysis

7.3. Global Nexobrid Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Nexobrid Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nexobrid Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nexobrid Market Segmentation

9.1. Global Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Topical Gel, Spray, Ointment

9.2. Global Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Burn Care, Chronic Wound Care, Trauma Care

9.3. Global Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Ambulatory Surgical Centers (ASCs), Retail Pharmacies, Online Pharmacies

9.4. Global Nexobrid Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Pediatric, Geriatric

10. Nexobrid Market Regional And Country Analysis

10.1. Global Nexobrid Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Nexobrid Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nexobrid Market

11.1. Asia-Pacific Nexobrid Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nexobrid Market

12.1. China Nexobrid Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nexobrid Market

13.1. India Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nexobrid Market

14.1. Japan Nexobrid Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nexobrid Market

15.1. Australia Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Nexobrid Market

16.1. South Korea Nexobrid Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Nexobrid Market

17.1. Western Europe Nexobrid Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Nexobrid Market

18.1. UK Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Nexobrid Market

19.1. Germany Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Nexobrid Market

20.1. France Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Nexobrid Market

21.1. Eastern Europe Nexobrid Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Nexobrid Market

22.1. North America Nexobrid Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Nexobrid Market

23.1. USA Nexobrid Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Nexobrid Market

24.1. Canada Nexobrid Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Nexobrid Market

25.1. South America Nexobrid Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Nexobrid Market

26.1. Middle East Nexobrid Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Nexobrid Market

27.1. Africa Nexobrid Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Nexobrid Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Nexobrid Market Regulatory and Investment Landscape

29. Nexobrid Market Competitive Landscape And Company Profiles

29.1. Nexobrid Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Nexobrid Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Nexobrid Market Company Profiles

29.3.1. MediWound Ltd. Overview, Products and Services, Strategy and Financial Analysis

30. Global Nexobrid Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Nexobrid Market

32. Nexobrid Market High Potential Countries, Segments and Strategies

32.1 Nexobrid Market In 2030 - Countries Offering Most New Opportunities

32.2 Nexobrid Market In 2030 - Segments Offering Most New Opportunities

32.3 Nexobrid Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Nexobrid Market, Overview Of Key Products - Product Examples
  • Table 2: Global Nexobrid Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Nexobrid Market, Supply Chain Analysis
  • Table 4: Global Nexobrid Market, Major Raw Material Providers
  • Table 5: Global Nexobrid Market, Major Resource Providers
  • Table 6: Global Nexobrid Market, Major Manufacturers (Suppliers)
  • Table 7: Global Nexobrid Market, Major Distributors And Channel Partners
  • Table 8: Global Nexobrid Market, Key Technologies & Future Trends
  • Table 9: Global Nexobrid Market, Major Trends
  • Table 10: Global Nexobrid Market, Major End Users
  • Table 11: Global Nexobrid Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Nexobrid Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Nexobrid Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Nexobrid Market - TAM, US$ Billion, 2025
  • Table 15: Global Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Nexobrid Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Nexobrid Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Nexobrid Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Global Nexobrid Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 73: Global Nexobrid Market - Company Scoring Matrix
  • Table 74: MediWound Ltd. Financial Performance
  • Table 75: Global Nexobrid Market, Competitive Benchmarking (In USD Billions)
  • Table 76: Global Nexobrid Market, Competitive Dashboard
  • Table 77: Global Nexobrid Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 78: Global, Nexobrid Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Table 79: Global, Nexobrid Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Table 80: Global, Nexobrid Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Nexobrid Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Nexobrid Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Nexobrid Market, Supply Chain Analysis
  • Figure 4: Global Nexobrid Market, Major Raw Material Providers
  • Figure 5: Global Nexobrid Market, Major Resource Providers
  • Figure 6: Global Nexobrid Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Nexobrid Market, Major Distributors And Channel Partners
  • Figure 8: Global Nexobrid Market, Key Technologies & Future Trends
  • Figure 9: Global Nexobrid Market, Major Trends
  • Figure 10: Global Nexobrid Market, Major End Users
  • Figure 11: Global Nexobrid Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Nexobrid Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Nexobrid Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Nexobrid Market - TAM, US$ Billion, 2025
  • Figure 15: Global Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Nexobrid Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Nexobrid Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Nexobrid Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Global Nexobrid Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 73: Global Nexobrid Market - Company Scoring Matrix
  • Figure 74: MediWound Ltd. Financial Performance
  • Figure 75: Global Nexobrid Market, Competitive Benchmarking (In USD Billions)
  • Figure 76: Global Nexobrid Market, Competitive Dashboard
  • Figure 77: Global Nexobrid Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 78: Global, Nexobrid Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Figure 79: Global, Nexobrid Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Figure 80: Global, Nexobrid Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Frequently Asked Questions

The Nexobrid Market Report 2026 market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030. request a sample here

The expected CAGR for the Nexobrid Market Report 2026 market during the forecast period 2025–2030 is %. request a sample here

Major growth driver of the market includes: Rising Prevalence Of Burn Injuries To Drive The Market Growth in the Nexobrid Market Report 2026 market. For further insights on this market, request a sample here

The nexobrid market covered in this report is segmented –
1) By Formulation: Topical Gel, Spray, Ointment
2) By Clinical Indication: Burn Care, Chronic Wound Care, Trauma Care
3) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Retail Pharmacies, Online Pharmacies
4) By End-User: Adult, Pediatric, Geriatric
request a sample here

Major trend in this market includes: Enhancing Emergency Preparedness With Advanced Burn Care Treatments For further insights on this market, request a sample here.

Major companies operating in the Nexobrid Market Report 2026 market are Major companies operating in the nexobrid market are MediWound Ltd. request a sample here.

North America was the largest region in the nexobrid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nexobrid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts